入院后接受苯二氮卓类药物或抗精神病药物治疗的临终关怀痴呆症患者面临更高的死亡率，引发了人们对过度使用和护理质量的担忧。 Dementia patients in hospice given benzodiazepines or antipsychotics after admission faced higher death rates, raising concerns about overuse and care quality.

一项针对临终关怀医院超过 139,000 名痴呆症患者的新研究发现，尽管之前没有使用过苯二氮卓类药物，但入组后服用苯二氮卓类药物或抗精神病药物的人在六个月内死亡的可能性分别高出 41% 和 16%。 A new study of over 139,000 dementia patients in hospice found those prescribed benzodiazepines or antipsychotics after enrollment were 41% and 16% more likely to die within six months, respectively, despite no prior use. 近一半的人在入院后不久接受了新的苯二氮卓类药物治疗，13% 的人接受了抗精神病药物治疗。 Nearly half received new benzodiazepines and 13% got antipsychotics soon after hospice admission. 平均停留时间超过130天,表明许多人没有接近寿命的结束。 The average stay exceeded 130 days, suggesting many were not near end-of-life. 研究人员警告这些与镇静剂、坠落和死亡率上升有关的药物可能被过度使用,这突出说明了监督方面的差距、过时的资格规定以及需要更好、个性化的护理。 Researchers warn these medications, linked to sedation, falls, and increased mortality, may be overused, highlighting gaps in oversight, outdated eligibility rules, and the need for better, individualized care.